| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |